CMS Ventures

InvestorScreen: DoneContacts: To Do

Description

CMS Ventures, launched in 2020, is the investment arm of China Medical System Holdings Limited (CMS), a well-established, innovation-driven specialty pharma founded in 1995, and listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 867). CMS Ventures receives supports from AstraZeneca and Cambridge Judge Business School. CMS Ventures provide patient capital for ambitious Biotech and Life Sciences start-ups in the 4Ds (Drugs, Devices, Diagnostics and Digital), interested in entering the Chinese market with a trusted partner of choice.

AI Sector Summary

CMS Ventures focuses exclusively on Biotech and Life Sciences, specifically within drugs, medical devices, diagnostics, and digital health, targeting companies looking to expand into the Chinese market.

Location

Cambridge, England, United Kingdom

Industry

Venture Capital and Private Equity Principals

Investor Type

venture capital

Target Sectors

healthcare, biotech, drugs, devices, diagnostics, digital

Verticals

HealthcareUK Search

Financials

Revenue

—

EBITDA

—

Employees

Founded

2019

Sectors (from search)

healthcare · Biotech, Life Sciences, Drugs, Devices, Diagnostics, Digital

Classify Status

Done

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.